-
1
-
-
84942240891
-
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
-
Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 2015; 59: 5873-84
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 5873-5884
-
-
Pitout, J.D.1
Nordmann, P.2
Poirel, L.3
-
3
-
-
85011085656
-
Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms
-
Temkin E, Torre-Cisneros J, Beovic B et al. Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms. Antimicrob Agents Chemother 2017; 61: e01964-16
-
(2017)
Antimicrob Agents Chemother
, vol.61
-
-
Temkin, E.1
Torre-Cisneros, J.2
Beovic, B.3
-
4
-
-
84995524184
-
Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections
-
Shields RK, Potoski BA, Haidar G et al. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 2016; 63: 1615-8
-
(2016)
Clin Infect Dis
, vol.63
, pp. 1615-1618
-
-
Shields, R.K.1
Potoski, B.A.2
Haidar, G.3
-
5
-
-
85018158691
-
Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum b-lactamases
-
Haidar G, Clancy CJ, Shields RK et al. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum b-lactamases. Antimicrob Agents Chemother 2017; 61: e02534-16
-
(2017)
Antimicrob Agents Chemother
, vol.61
-
-
Haidar, G.1
Clancy, C.J.2
Shields, R.K.3
-
6
-
-
85014206835
-
Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections
-
Shields RK, Chen L, Cheng S et al. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 2017; 61: e02097-16
-
(2017)
Antimicrob Agents Chemother
, vol.61
-
-
Shields, R.K.1
Chen, L.2
Cheng, S.3
-
7
-
-
85021816193
-
High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
-
Shen Z, Ding B, Ye M et al. High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 2017; 72: 1930-6
-
(2017)
J Antimicrob Chemother
, vol.72
, pp. 1930-1936
-
-
Shen, Z.1
Ding, B.2
Ye, M.3
-
8
-
-
85019677848
-
Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3
-
Humphries RM, Hemarajata P. Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3. Antimicrob Agents Chemother 2017; 61: e00537-17
-
(2017)
Antimicrob Agents Chemother
, vol.61
-
-
Humphries, R.M.1
Hemarajata, P.2
-
10
-
-
84878275967
-
Evaluation of phenotypic and genotypic approaches for the detection of class A and class B carbapenemases in Enterobacteriaceae
-
Ambretti S, Gaibani P, Berlingeri A et al. Evaluation of phenotypic and genotypic approaches for the detection of class A and class B carbapenemases in Enterobacteriaceae. Microb Drug Resist 2013; 19: 212-5
-
(2013)
Microb Drug Resist
, vol.19
, pp. 212-215
-
-
Ambretti, S.1
Gaibani, P.2
Berlingeri, A.3
-
11
-
-
84920154702
-
Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics
-
Gaiarsa S, Comandatore F, Gaibani P et al. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics. Antimicrob Agents Chemother 59: 389-96
-
Antimicrob Agents Chemother
, vol.59
, pp. 389-396
-
-
Gaiarsa, S.1
Comandatore, F.2
Gaibani, P.3
-
12
-
-
84965190732
-
The Harvest suite for rapid coregenome alignment and visualization of thousands of intraspecific microbial genomes
-
Treangen TJ, Ondov BD, Koren S et al. The Harvest suite for rapid coregenome alignment and visualization of thousands of intraspecific microbial genomes. GenomeBiol 2014; 15: 524
-
(2014)
GenomeBiol
, vol.15
, pp. 524
-
-
Treangen, T.J.1
Ondov, B.D.2
Koren, S.3
-
13
-
-
84891776599
-
PATRIC, the bacterial bioinformatics database and analysis resource
-
Wattam AR, Abraham D, Dalay O et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res 2014; 42: D581-91
-
(2014)
Nucleic Acids Res
, vol.42
, pp. D581-D591
-
-
Wattam, A.R.1
Abraham, D.2
Dalay, O.3
-
14
-
-
84949194114
-
Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment
-
Liu Q, Via LE, Luo T et al.Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment. Sci Rep 2015; 5: 17507
-
(2015)
Sci Rep
, vol.5
, pp. 17507
-
-
Liu, Q.1
Via, L.E.2
Luo, T.3
-
15
-
-
84875578097
-
Using Tablet for visual exploration of second-generation sequencing data
-
Milne I, Stephen G, Bayer M et al. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 2013; 14: 193-202
-
(2013)
Brief Bioinform
, vol.14
, pp. 193-202
-
-
Milne, I.1
Stephen, G.2
Bayer, M.3
-
16
-
-
84871227763
-
LoFreq: a sequence-quality aware, ultrasensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets
-
Wilm A, Aw PP, Bertrand D et al. LoFreq: a sequence-quality aware, ultrasensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012; 40: 11189-201
-
(2012)
Nucleic Acids Res
, vol.40
, pp. 11189-11201
-
-
Wilm, A.1
Aw, P.P.2
Bertrand, D.3
-
17
-
-
84995380111
-
Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak
-
Halaby T, Kucukkose E, Janssen AB et al. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob Agents Chemother 2016; 60: 6837-43
-
(2016)
Antimicrob Agents Chemother
, vol.60
, pp. 6837-6843
-
-
Halaby, T.1
Kucukkose, E.2
Janssen, A.B.3
-
18
-
-
84933531045
-
Impact of a hospital-widemultifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy
-
Viale P, Tumietto F, Giannella M et al. Impact of a hospital-widemultifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect 2015; 21: 242-7
-
(2015)
Clin Microbiol Infect
, vol.21
, pp. 242-247
-
-
Viale, P.1
Tumietto, F.2
Giannella, M.3
-
19
-
-
85018185416
-
In vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases
-
Shields RK, Nguyen MH, Press EG et al. In vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases. Antimicrob Agents Chemother 2017; 61: e00079-17
-
(2017)
Antimicrob Agents Chemother
, vol.61
-
-
Shields, R.K.1
Nguyen, M.H.2
Press, E.G.3
-
20
-
-
85030534150
-
Klebsiella pneumoniae (ST1519) producing KPC-19 carbapenemase in a patient undergoing selective digestive decontamination before liver transplant
-
Centonze AR, Azzini AM, Mazzi R et al. Klebsiella pneumoniae (ST1519) producing KPC-19 carbapenemase in a patient undergoing selective digestive decontamination before liver transplant. Clin Microbiol Infect 2018; 24: 203-4
-
(2018)
Clin Microbiol Infect
, vol.24
, pp. 203-204
-
-
Centonze, A.R.1
Azzini, A.M.2
Mazzi, R.3
|